ArticleCell death & disease2022
Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma.
Qi Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleCell death & disease2022
Qi Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.